September 19, 2011 – CapsoVision’s initial product offering includes the CapsoCam SV1, an innovative GI capsule endoscopy system for the diagnosis of small bowel diseases including bleeding, cancer, celiac and Crohn’s disease. CapsoVision’s CapsoCam SV1 provides a new standard in capsule endoscopy, providing 360 degree imaging of the intestinal wall. The capsule records and self-stores the data, thus eliminating the need for cumbersome external recording harnesses required by first generation capsule endoscopy products.
Commenting on the agreement, CapsoVision’s CEO and Chief Technical Officer, Johnny Wang said, “The agreement with Werfen Austria is another important step forward for CapsoVision. We are excited to be partnering with Werfen Austria to promote and distribute our products to the medical community in Austria. We are very happy that Werfen Austria shares our enthusiasm and vision, and we look forward to a long term relationship. Leading physicians who have participated in our clinical trials are excited about our product’s ease of use and the outstanding detection results that have been achieved.”